The estimated Net Worth of Christopher D. Brown is at least $8.82 Millón dollars as of 7 August 2024. Dr Brown owns over 6,328 units of 908 Devices stock worth over $3,110,714 and over the last 4 years he sold MASS stock worth over $5,708,651.
Dr has made over 20 trades of the 908 Devices stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 6,328 units of MASS stock worth $9,998 on 7 August 2024.
The largest trade he's ever made was selling 35,000 units of 908 Devices stock on 7 July 2021 worth over $1,177,050. On average, Dr trades about 10,975 units every 47 days since 2020. As of 7 August 2024 he still owns at least 891,322 units of 908 Devices stock.
You can see the complete history of Dr Brown stock trades at the bottom of the page.
Dr. Christopher David Brown Ph.D. is the Co-Founder, CTO, VP of R&D and Member of Scientific Advisory Board at 908 Devices.
Dr D is 46, he's been the Co-Founder, CTO y VP of R&D and Member of Scientific Advisory Board of 908 Devices since . There are 4 older and no younger executives at 908 Devices. The oldest executive at 908 Devices Inc. is Michael S. Turner Esq., J.D., 54, who is the VP, Sec. & Gen. Counsel.
Christopher's mailing address filed with the SEC is C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON, MA, 02210.
Over the last 4 years, insiders at 908 Devices have traded over $16,182,689 worth of 908 Devices stock and bought 826,585 units worth $15,798,345 . The most active insiders traders include Keith Crandell, Kevin J. Knopp y E Kevin Hrusovsky. On average, 908 Devices executives and independent directors trade stock every 10 days with the average trade being worth of $64,663. The most recent stock trade was executed by Christopher D. Brown on 7 August 2024, trading 6,328 units of MASS stock currently worth $9,998.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
908 Devices executives and other stock owners filed with the SEC include: